Deuterium-enriched ondansetron

Details Deuterium-enriched ondansetron Deuterium-enriched ondansetron

2011-04-05

2011-04-05

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S311400

Reexamination Certificate

active

07919516

ABSTRACT:
The present application describes deuterium-enriched ondansetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

REFERENCES:
patent: 4695578 (1987-09-01), Coates et al.
patent: 6221335 (2001-04-01), Foster
patent: 6440710 (2002-08-01), Keinan et al.
patent: 6603008 (2003-08-01), Ando et al.
patent: 7517990 (2009-04-01), Ito et al.
patent: 2007/0082929 (2007-04-01), Gant et al.
patent: 2007/0197695 (2007-08-01), Potyen et al.
patent: 95/26325 (1995-10-01), None
[Dyck, L.E., Effects of Deuterium Substitution on the Catabolism of beta-Phenylethylamine: An In Vivo Study, Journal of Neurochemistry, 46(2) (1986) 399-404.].
[Tonn, G.R. Simultaneous Analysis of Diphenhydramine and a Stable Isotope Analog (2H10) Diphenhydramine Using Capillary Gas Chromatography with Mass Selection Detection in Biological Fluids from Chronically Instrumented Pregnant Ewes. Biological Mass Spectrometry, 22(11) (1993) 633-642.].
[Haskins, N. J. The Application of Stable Isotopes in Biomedical Research. Biomedical Spectrometry 9(7) (1982) 269-277.].
[Wolen, Robert L. The Application of Stable Isotopes to Studies of Drug Bioavailability and Bioequivalence. Journal of Clinical Pharmacology, (26) (1986) 419-424.].
[Browne, Thomas R. Stable Isotope Techniques in Early Drug Development: An Economic Evaluation. Journal of Clinical Pharmacology, (38) (1998) 213-220.].
[Baillie, Thomas A. The Use of Stable Isotopes in Pharmacological Research. Pharmacology Rev. (33) (1981) 81-132.].
[Gouyette, Alain. Synthesis of Deuterium-labeled Elliptinium and its Use in Metabolic Studies. Biomedical and Environmental Mass Spectrometry, (15) (1988), 243-247.].
[Cherrah, Y., Study of Deuterium Isotope Effects on Protein Binding by Gas Chromatography/Mass Spectrometry. Caffeine and Deuterated Isotopomers. Biomedical and Environmental Mass Spectrometry, 14(11) (1987) 653-657.].
[Pieniaszek, Henry J., Moricizine Bioavailability via Simultaneous, Dual, Stable Isotope Administration: Bioequivalence Implications. J. Clinical Pharmacology, (39) (1999) 817-825.].
[Honma, Seijiro. The Metabolism of Roxatidine Acetate Hydrochloride. Drug Metabolism and Disposition. 15(4) (1987) 551-559.].
Kushner, D.J.; Pharmacological Uses and Perspectives of Heavy Water and Deuterated Compounds; Canadian Journal of Physiology and Pharmacology 1999, 77(2), 79-88.
Somers, G.I. et al., The metabolism of the 5HT3 antagonists ondansetron, alosetron and GR87442 I: A comparison of in vitro and in vivo metabolism and in vitro enzyme kinetics in rat, dog and human hepatocytes, microsomes and recombinant human enzymes. Xenobiotica 2007, 37(8), 832-54.
Yamamoto, T. et al., Synthesis and Configurational Stability of (S)- and (R)-Deuteriuthalidomides. Chem. Pharm. Bull. 2010, 58(1), 110-112.

Affiliated with

Also associated with

Rating

Deuterium-enriched ondansetron does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deuterium-enriched ondansetron, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deuterium-enriched ondansetron will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2666073